Skip to main content

Table 1 Clinical testing summary

From: Design and validation of an oligonucleotide microarray for the detection of genomic rearrangements associated with common hereditary cancer syndromes

Syndrome

Gene(s) tested

Patients testeda

Total positive sequence and LR mutations

Total LR (% of positive mutations)

LR by gene (% of LR)

HBOC

BRCA1

13,124

2,186

185 (8.5%)

167 (90.3%)

BRCA2

18 (9.7%)

Lynch syndrome

MLH1

18,498

1,098

189 (17.2%)

51 (27.0%)

MSH2

109 (57.7%)

MSH6

10 (5.3%)

EPCAM

8 (4.2%)

EPCAM/MSH2

11 (5.8%)

Polyposis

APC

2,739

324

31 (9.6%)

31 (100%)

  1. aSequencing and rearrangement testing done concurrently.